Back To: Home : Featured Technology : Reagents/Proteins

CLICK HERE FOR WHAT'S NEW IN:
 

Nodality gains patent for tech platform
September 2014
SHARING OPTIONS:

SOUTH SAN FRANCISCO, Calif.—The U.S. Patent and Trademark Office has issued U.S. Patent No. 8,815,527, “Methods and Compositions for Detecting the Activation State of Multiple Proteins in Single Cells,” to Nodality Inc. The patent claims cover systems for establishing the activation state of more than one protein in a cell, where the system can use any detector, including cytometers and mass spectrometers. The patent, which Nodality has exclusively licensed from Stanford University, will expire after September 2023. Nodality holds “more than 30 issued and allowed patents in the U.S. and abroad, with over 260 issued claims,” according to Laura Brege, president and CEO of Nodality.
 
“The ‘527 patent is another important protection for our multifaceted approach to improving drug development through diverse applications of our Single Cell Network Profiling platform,” Brege commented in a news release.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.